Document 0286 DOCN M9460286 TI HIV-1 Nef activity in murine T cells. CD4 modulation and positive enhancement. DT 9408 AU Rhee SS; Marsh JW; Laboratory of Molecular Biology, National Institute of Mental; Health, Bethesda, MD 20892. SO J Immunol. 1994 May 15;152(10):5128-34. Unique Identifier : AIDSLINE MED/94230994 AB Immediately after infection of the targeted cell by HIV-1, proviral gene expression is limited to the three regulatory proteins, Tat, Rev, and Nef, with the nef transcript representing nearly 80% of total expression. Additionally, simian immunodeficiency virus Nef has been shown to be essential for high in vivo titer and the development of immunodeficiency. Recent findings demonstrate that the negative effects of Nef expression, as first defined in transformed T cell lines, are not present when Nef is expressed in primary human T cells or in T cells from transgenic mice, in which one sees moderate positive enhancements of HIV replication and the T cell activation process, respectively. We find that Nef expression in an Ag-specific murine T cell hybridoma results in both the down-modulation of CD4, as seen in primary cells and human T cell lines, and a positive enhancement of the TCR response to stimuli. Examination of a CD4- cell demonstrated that the positive enhancement is independent of CD4 expression or modulation. CD4 down-modulation is shown to be caused by a post-Golgi, acid-dependent process, which dramatically decreases the lifespan of the CD4 molecule. The TCR, Thy Ag, and CD45 remained unchanged in their surface expression. These findings suggest that Nef alters the normal routing and residencies of the CD4 molecule and that the positive effect of Nef on T cell activation is independent of this modulation. DE Animal Antigens, CD4/*ANALYSIS Cell Line Down-Regulation (Physiology) Gene Products, nef/*PHYSIOLOGY HIV-1/*PATHOGENICITY Interleukin-2/BIOSYNTHESIS Lymphocyte Transformation Mice Receptors, Antigen, T-Cell/PHYSIOLOGY Support, U.S. Gov't, P.H.S. T-Lymphocytes/*IMMUNOLOGY JOURNAL ARTICLE SOURCE: National Library of Medicine. NOTICE: This material may be protected by Copyright Law (Title 17, U.S.Code).